REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/21/2025
Back to search
Official data from USPTO
LUVICI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LUVICI
ST13
US500000079273188Class
5, 9, 44
Filing
79273188
Registration
6035995
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
04/22/2025
Trademark type
Word
Nice classes
5, 9, 44
Filing date
09/25/2019
Registration date
04/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2020
Last transaction
04/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
MORRIS, KRISTINA
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5Class 9Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 9
Downloadable mobile software applications for use in disease treatment and tracking patient compliance with medical treatments
Class 44
Medical servicesproviding healthcare information for patients and healthcare providers
Publications
History of USPTO decisions and trademark events.
21 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/22/2020
FIMP
FINAL DISPOSITION PROCESSED
06/22/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
05/21/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/18/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/18/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/18/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/18/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/18/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/18/2020
PUBO
PUBLISHED FOR OPPOSITION
02/04/2020
NPUB
NOTICE OF PUBLICATION
01/15/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/28/2019
DOCK
ASSIGNED TO EXAMINER
12/23/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/12/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/05/2019
Continuous trademark protection
Get notified about every new filing that threatens LUVICI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.